2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Gorlin Syndrome: new trials by email Literature Review of Gorlin Syndrome trials Research Report on Gorlin Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) LDE225, Placebo - Basal Cell Carcinoma, Gorlin Syndrome | Phase 2 | Completed | Novartis Pharmaceuticals | 10 | 2011-04-01 | 2015-10-19 |
| To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) GDC-0449 - Basal Cell Nevus Syndrome, Gorlin Syndrome | Phase 2 | Completed | UCSF Benioff Children's Hospital Oakland | 41 | 2009-08-01 | 2021-01-11 |
Basal Cell Nevus Syndrome (2) · Carcinoma, Basal Cell (1)
Abnormalities, Multiple (2) · Bone Cysts (2) · Bone Diseases (2) · Bone Diseases, Developmental (2) · Carcinoma (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Cysts (2) · Genetic Diseases, Inborn (2) · Jaw Cysts (2) · Jaw Diseases (2) · Musculoskeletal Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Basal Cell (2)
HhAntag691 (1) · sonidegib (1)
Novartis Pharmaceuticals (1) · UCSF Benioff Children's Hospital Oakland (1)
Austria (1) · Belgium (1) · Canada (1) · Germany (1) · United States (1)